Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Lannett Co Inc (LCI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 891,605
  • Shares Outstanding, K 37,700
  • Annual Sales, $ 633,340 K
  • Annual Income, $ -580 K
  • 36-Month Beta 2.85
  • Price/Sales 1.47
  • Price/Cash Flow 5.65
  • Price/Book 1.60

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.15 +8.35%
on 01/18/18
27.23 -11.85%
on 12/20/17
-2.50 (-9.43%)
since 12/19/17
3-Month
19.50 +23.08%
on 10/31/17
30.35 -20.92%
on 12/13/17
-0.50 (-2.04%)
since 10/19/17
52-Week
14.90 +61.07%
on 08/15/17
30.35 -20.92%
on 12/13/17
+4.80 (+25.00%)
since 01/19/17

Most Recent Stories

More News
Lannett Co Inc Set to Possibly Rebound After Yesterday's Selloff of 5.45%

Lannett Co Inc (NYSE:LCI) traded in a range yesterday that spanned from a low of $22.15 to a high of $24.80. Yesterday, the shares fell 5.5%, which took the trading range below the 3-day low of $24.30...

LCI : 24.20 (+2.33%)
Lannett Names Timothy C. Crew To Board Of Directors

Lannett Company, Inc. (NYSE: LCI) today announced that Timothy C. Crew, the company's recently appointed chief executive officer (CEO), has been added to the Lannett Company Board of Directors. With this...

LCI : 24.20 (+2.33%)
Haeggquist & Eck Investigates Breach of Fiduciary Duties by Lannett Officers and Directors Related to Criminal Investigation into Potential Price Collusion

Haeggquist & Eck, LLP, a leading shareholder rights litigation firm, is investigating whether certain directors and officers of Lannett Company, Inc. ("Lannett" or the "Company") (NYSE:...

LCI : 24.20 (+2.33%)
Free Post Earnings Research Report: Lannett Co.'s Revenue Grew 4.1%

LONDON, UK / ACCESSWIRE / December 19, 2017 / Active-Investors free earnings report on Lannett Co., Inc. (NYSE: LCI) has freshly been issued to its members, and you can also sign up to view this report...

LCI : 24.20 (+2.33%)
Robbins Arroyo LLP Is Investigating the Officers and Directors of Lannett Company, Inc. (LCI) on Behalf of Shareholders

Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Lannett Company, Inc. (NYSE: LCI) breached their fiduciary duties to shareholders....

LCI : 24.20 (+2.33%)
Lannett To Participate At Two Investment Conferences In December

Lannett Company, Inc. (NYSE: LCI) today announced that the company will present at the BMO Capital Markets 2017 Prescription for Success Healthcare Conference on December 14, 2017 at 3:30 p.m. (ET) at...

LCI : 24.20 (+2.33%)
Lannett Announces FDA Acceptance Of 505(b)(2) New Drug Application For Cocaine Hydrochloride Topical Solution, A Proprietary Anesthetic Product

Lannett Company, Inc. (NYSE: LCI) today announced that the 505(b)(2) New Drug Application (NDA) for Cocaine Hydrochloride (HCl) Topical Solution, 4% and 10%, with a proposed trade name of Numbrino(TM),...

LCI : 24.20 (+2.33%)
Scott+Scott, Attorneys at Law, LLP is Investigating Derivative Claims on Behalf of Shareholders of Lannett Company, Inc.

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is investigating whether certain directors and officers of Lannett Company,...

LCI : 24.20 (+2.33%)
Stock Performance Review on Generic Drugs Industry -- pSivida, Tetraphase Pharma, Catalent, and Lannett

If you want a Stock Review on PSDV, TTPH, CTLT, or LCI then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. On Tuesday, the NASDAQ Composite ended the day...

PSDV : 1.08 (-0.92%)
LCI : 24.20 (+2.33%)
CTLT : 42.53 (+0.26%)
TTPH : 6.31 (-1.43%)
Scott+Scott, Attorneys at Law, LLP is Investigating Derivative Claims on Behalf of Shareholders of Lannett Company, Inc. (LCI)

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is investigating whether certain directors and officers of Lannett Company, Inc. ("Lannett"...

LCI : 24.20 (+2.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More

Business Summary

Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a wide range of therapeutic areas. Lannett believes that their ability to select viable...

See More

Key Turning Points

2nd Resistance Point 26.18
1st Resistance Point 24.92
Last Price 24.20
1st Support Level 22.27
2nd Support Level 20.88

See More

52-Week High 30.35
Fibonacci 61.8% 24.45
Last Price 24.20
Fibonacci 50% 22.63
Fibonacci 38.2% 20.80
52-Week Low 14.90

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.